Literature DB >> 9025157

The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981.

Y Najean1, J D Rain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9025157

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

Review 1.  Polycythemia vera.

Authors:  Raffaele Landolfi; Maria Anna Nicolazzi; Angelo Porfidia; Leonardo Di Gennaro
Journal:  Intern Emerg Med       Date:  2010-03-16       Impact factor: 3.397

Review 2.  Therapeutic radionuclides in nuclear medicine: current and future prospects.

Authors:  Chai-Hong Yeong; Mu-hua Cheng; Kwan-Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

Review 3.  Polycythaemia vera and essential thrombocythaemia in the elderly.

Authors:  P J van Genderen; M M Troost
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

4.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

5.  Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.

Authors:  Omar Abdel-Wahab; Taghi Manshouri; Jay Patel; Kelly Harris; Jinjuan Yao; Cyrus Hedvat; Adriana Heguy; Carlos Bueso-Ramos; Hagop Kantarjian; Ross L Levine; Srdan Verstovsek
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 6.  Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).

Authors:  Jan Jacques Michiels; Juergen Thiele
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.

Authors:  Jie Bai; Yangping Xue; Lei Ye; Jianfeng Yao; Chunlin Zhou; Zonghong Shao; Linsheng Qian; Renchi Yang; Haiyan Li; Hongyun Zhang; Yizhou Zheng
Journal:  Int J Hematol       Date:  2008-11-11       Impact factor: 2.490
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.